Umeå University is one of Sweden’s largest higher education institutions with over 37,000 students and about 4,700 employees. The University offers a diversity of high-quality education and world-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything is close. Our cohesive campuses make it easy to meet, work together and exchange knowledge, which promotes a dynamic and open culture.
The ongoing societal transformation and large green investments in northern Sweden create enormous opportunities and complex challenges. For Umeå University, conducting research about – and in the middle of – a society in transition is key. We also take pride in delivering education to enable regions to expand quickly and sustainably. In fact, the future is made here.
Are you interested in learning more? Read here
The Faculty of Medicine, which consists of 12 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.
The Department of Diagnostics and Intervention is offering a postdoctoral scholarship within the project “Novel biomarkers for personalized pancreatic cancer treatment” in Oskar Franklin’s research group. The research group is part of the Northern Sweden Pancreatic Network, a research network of national and international clinicians and researchers interested in pancreatic cancer and pancreatic disease. The scholarship is full-time for two years with access from August 17, 2026, or by agreement.
Project description
To improve outcomes in pancreatic cancer, there is a critical need to personalize cancer care based on tumor biology. This postdoctoral scholarship is connected to a research project that aims to identify new biomarkers that forecast survival and treatment response, and to understand their functional roles. The project investigates protein expression, functional characteristics, and biomarker potential of a number of candidate genes identified in previous studies.
The project encompasses the study of protein levels in tissue microarrays constructed from surgical specimens, as well as the measurement of corresponding protein levels in biobanked blood samples. It also includes opportunities to explore how these genes influence pancreatic cancer cell proliferation, migration, and invasion using over‑expression and knockdown approaches in cultured cells and organoids. Understanding the functional aspects of these genes may open new possibilities for treatments that target their signalling pathways.
The research is carried out within the Translational Research Center at Umeå University, located at Norrlands Universitetssjukhus, offering a collaborative and inspiring environment where basic and clinical research naturally meet.
The postdoctoral fellow will have the opportunity to:
Qualifications
Postdoctoral scholarships aim to promote internationalization and contribute to further research qualifications after obtaining doctoral degree or its equivalent.
To qualify as a postdoctoral scholarship holder, the postdoctoral fellow is required to have completed a doctoral degree or a foreign degree deemed equivalent to a doctoral degree. The degree must be from a university outside Sweden. This qualification requirement must be fulfilled no later than at the time of the decision about scholarship recipient.
Priority should be given to candidates who completed their doctoral degree, according to what is stipulated in the paragraph above, no later than three years prior. If there are special reasons, candidates who completed their doctoral degree before that may also be eligible. Special reasons include absence due to illness, parental leave, appointments of trust in trade union organisations, military service or similar circumstances, as well as clinical practice or other forms of appointment/assignment relevant to the subject area.
Doctoral degree should be within molecular biology, cancer biology, biomedical sciences, pathology, or a related field.
Additional requirements are:
Meriting criteria are:
We are looking for candidates with an interest in translational cancer research—particularly biomarker discovery and tumour biology—who show motivation to develop as independent researchers in a multidisciplinary environment.
Application
The application should be written in English or Swedish, and attached documents should be in Word or PDF format. The application should be registered via Umeå University’s e-recruitment system Varbi and submitted by the deadline April 1, 2026.
A full application should include:
Further information
For further information, please contact Oskar Franklin, M.D., Ph.D. oskar.franklin@umu.se
We look forward to receiving your application!
| First day of employment | According to agreement |
|---|---|
| Salary | Stipendium |
| Full-time equivalent | 100 |
| City | Umeå |
| County | Västerbottens län |
| Country | Sweden |
| Reference number | FS 2.1.6-347-26 |
| Contact |
|
| Published | 09.Feb.2026 |
| Last application date | 01.Apr.2026 |